FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, more specifically to an antiviral and interferonogenic amison preparation. The offered drug preparation is presented in the form of a capsule and contains the active substance amison (55.0-85.0 wt %) and target additives: lactose (11.0-44.0 wt %), aerosil (0.1-1.0 wt %), magnesium or calcium stearate (0.5-1.2 wt %) and talc (0-3.0 wt %).
EFFECT: invention provides the oral dosage form of amison for the first time presented in the form of capsules, storage-stable and enabling fast and complete release of the active substance.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL DRUG AS CAPSULES AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2633085C2 |
| ORAL PHARMACEUTICAL COMPOSITION MEMANTIN (OPTIONS) AND METHOD OF PREPARATION (OPTIONS) | 2007 |
|
RU2326660C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLID PERORAL MEDICINAL FORM, CONTAINING SYGETHINUM (VERSIONS) | 2007 |
|
RU2338523C1 |
| ORAL GINDARINE MEDICINE AND PRODUCTION METHOD | 2007 |
|
RU2360675C1 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| TABLETTED ANTIVIRAL AGENT AND METHOD FOR PREPARING IT | 2010 |
|
RU2446802C2 |
| PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
| ENCAPSULATED ANTIVIRAL MEDICATION AND ITS PRODUCTION METHOD | 2011 |
|
RU2451514C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF THYROID DISEASES | 2017 |
|
RU2655307C1 |
